How SAP Cleared a Complex Multinational Merger with SAMR: A Competition Law Case Study

Date:

Share post:

How SAP Cleared a Complex Multinational Merger with SAMR: A Competition Law Case Study

In 2018, SAP initiated an $8 billion acquisition of Qualtrics, a deal that required a rigorous 12-month review by China’s State Administration for Market Regulation (国家市场监督管理总局, SAMR, guójiā shìchǎng jiāndū guǎnlǐ zǒngjú). This case study examines how SAP secured conditional approval without divestitures, offering a masterclass in multinational merger clearance in China. By proactively addressing SAMR’s concerns around market definition, data sovereignty, and competitive effects, SAP set a precedent for how global technology companies can successfully navigate China’s increasingly sophisticated antitrust enforcement under the Anti-Monopoly Law (反垄断法, fǎn lǒng duàn fǎ).

The Case at a Glance: SAP Acquires Qualtrics

SAP, the German enterprise software giant, announced its intent to acquire Qualtrics, a US-based experience management (XM) platform, in November 2018 for roughly $8 billion. The goal was vertical expansion: combining SAP’s dominant Enterprise Resource Planning (ERP) and back-office software with Qualtrics’ customer, employee, and product experience front-end tools. This created a “closed loop” from operational data (O-data) to experience data (X-data).

Globally, the deal faced relatively light scrutiny. The European Commission and US Department of Justice cleared it quickly. However, SAMR subjected the deal to a full Phase II review, lasting the statutory maximum of 180 days. The reason was not just market share, but the strategic importance of enterprise software to China’s digital economy and the presence of strong domestic challengers like Yonyou (用友) and Kingdee (金蝶).

Data Point Detail
Acquiring Party SAP SE (Germany)
Target Party Qualtrics International Inc. (USA)
Deal Value $8 Billion (Enterprise Software / SaaS)
Reviewing Agency SAMR (State Administration for Market Regulation)
Review Duration ~12 Months (30 days Phase I / 90 days Phase II / 60 days Extended Phase II)
China Revenue Threshold Trigger > RMB 2B (approx $280M) in China for both parties combined
SAP Market Share (China ERP) ~33%
Primary Theory of Harm Conglomerate bundling / Data advantage foreclosure
Outcome Conditional Approval (Behavioral Remedies)

Why SAMR Scrutinized a B2B Software Merger

Many foreign executives assume that Chinese regulators care less about B2B software markets than they do about consumer internet or hard infrastructure. The SAP/Qualtrics case proved this assumption wrong. SAMR focused on three specific areas of concern that are now standard in global tech merger reviews.

Jurisdictional Thresholds and Market Definition. Under China’s law on concentration of operators (经营者集中, jīngyíngzhě jízhōng), deals exceeding global turnover of RMB 10B and individual China turnover of RMB 400M must be notified. SAP and Qualtrics easily cleared this bar. However, market definition became the central battleground. SAP argued that ERP and Experience Management software were distinct markets. SAMR, however, viewed them as parts of a broader “enterprise digital transformation” ecosystem, increasing the perceived competitive overlap and raising the standard of proof required for clearance.

Data Accumulation as a Barrier to Entry. SAMR introduced a sophisticated argument around data aggregation (数据积累, shùjù jīlěi). The combined entity would control vast datasets spanning financial operations (SAP) and human sentiment (Qualtrics). SAMR posited that this data moat would make it impossible for domestic rivals to compete, effectively foreclosing the Chinese enterprise SaaS market. This argument was novel at the time but has since become a staple in SAMR’s review of digital economy mergers.

Conglomerate Effects and Bundling. The primary theory of harm was not horizontal overlap (the two companies were not direct competitors), but conglomerate effects. SAMR feared that SAP would leverage its monopoly position in ERP to force customers to adopt Qualtrics, or that it would degrade interoperability between Qualtrics and competing Chinese ERP systems. This “bundling concern” required specific, verifiable commitments from SAP to be resolved.

SAP’s Strategy for SAMR Approval: Remedies, Data Compliance, and Timeline

SAP’s legal and regulatory team employed a three-pronged strategy to navigate the SAMR review. This strategy is now considered a blueprint for foreign tech companies seeking approval for complex vertical or conglomerate mergers in China.

Prong 1: Early and Transparent Engagement. Instead of treating China as a “last-stop” filing, SAP engaged SAMR informally months before the formal submission. This allowed the company to understand SAMR’s preliminary theories of harm and begin preparing evidence to counter them. SAP submitted a robust “China-specific” competitive analysis, distinct from the filings made in Europe or the United States.

Prong 2: Offering Concrete Behavioral Remedies. Knowing that structural remedies (like divesting overlapping assets) were inappropriate for a vertical deal, SAP prepared a comprehensive package of behavioral remedies (限制性条件, xiànzhìxìng tiáojiàn) early in the Phase II review. The key commitments included:

  • Non-Discrimination: A legally binding commitment not to force SAP ERP customers to purchase Qualtrics. Customers retained the freedom to choose any experience management provider.
  • Interoperability & Open APIs: A guarantee that Qualtrics would maintain interoperability with competing Chinese enterprise software platforms (e.g., Yonyou, Kingdee) on commercially reasonable terms.
  • Data Ring-Fencing: A clear separation of Qualtrics’ China customer data from SAP’s global data architecture. This addressed SAMR’s concerns about data aggregation and potential misuse of sensitive Chinese enterprise data.

Prong 3: Addressing the “Data Sovereignty” Subtext. Although the formal review was an antitrust matter, the subtext involved China’s emerging data security framework. SAP committed to ensuring that the merged entity’s operations in China would comply with the spirit of the then-upcoming Data Security Law (DSL) and Personal Information Protection Law (PIPL). By explicitly linking its remedies to China’s data sovereignty goals, SAP turned a potential liability into a point of alignment with the regulator.

Timeline of Key Events:

  1. November 2018: Deal announced. SAP begins informal dialogue with SAMR.
  2. January 2019: Formal filing submitted to SAMR.
  3. February 2019: Phase I review expires. SAMR identifies serious competition concerns, moving to Phase II.
  4. March-April 2019: Phase II review. SAMR conducts market tests, surveying domestic competitors and customers. SAP submits draft remedy package.
  5. April-May 2019: Extended Phase II. SAMR tests the effectiveness of the remedies with third parties. SAP appoints a monitoring trustee.
  6. May 2019: SAMR grants conditional approval. The deal closes globally shortly after.

Lessons for Foreign Executives: The SAMR Playbook for Tech Mergers

The SAP/Qualtrics case provides a high-resolution map for navigating SAMR clearance. The key is to move from a defensive posture to a proactive, China-specific engagement strategy. Below are three critical pitfalls to avoid and a decision framework to guide your approach.

Three Critical Pitfalls in the SAP Case

Pitfall: Underestimating the breadth of SAMR’s market definition. SAP initially argued that ERP and Experience Management were separate markets. SAMR defined the market broadly as “enterprise software ecosystems,” increasing the perceived competitive overlap and triggering a full Phase II review. Cost: Extended review timeline of 60+ days, correlating to millions in legal, consulting, and management distraction costs (est. RMB 8-12M over the extended period). Fix: Always prepare a “China-specific market definition” analysis that anticipates SAMR’s tendency to view digital products as ecosystem inputs, rather than standalone goods. Win the market definition battle early.
Pitfall: Ignoring the data aggregation angle in pre-merger planning. The deal team focused on traditional antitrust metrics (market share) and completely missed SAMR’s growing focus on data accumulation as a standalone theory of harm. This forced the legal team to scramble for data governance solutions mid-review. Cost: Risk of outright prohibition if data concerns are not adequately addressed. Even with resolution, it cost SAP significant negotiating leverage, leading to stricter data ring-fencing requirements than initially anticipated. Fix: Include a “Data Flow and Sovereignty” chapter in your initial filing. Map out how the merged entity will handle China customer data, separate it from global systems, and comply with the DSL and PIPL

Related articles

How a Foreign Biotech Startup Entered China’s Precision Medicine Market: Case Study

How a Foreign Biotech Startup Entered China's Precision Medicine Market: Case Study In 2023, NovaOnco Therapeutics, a US-based AI biotech startup, exe

How Legend Biotech Secured FDA Approval for CAR-T Therapy: Case Study

How Legend Biotech Secured FDA Approval for CAR-T Therapy: A China Biotech Case Study This case study examines how Legend Biotech (传奇生物, Legend Biotec

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study body{font-family:'Segoe UI',Tahoma,Geneva,Verdana,sans-serif;line-height:

How BeiGene Built a Billion-Dollar Biotech in China: Case Study

How BeiGene Built a Billion-Dollar Biotech in China: Case Study How BeiGene Built a Billion-Dollar Biotech in China: Case Study The story of BeiGene's